Utama › Penyakit Graft-versus-host › Ohio
Kajian klinikal Penyakit Graft-versus-host di Ohio
7 kajian untuk Penyakit Graft-versus-host sedang mencari peserta di lokasi di Ohio.
Bandar di Ohio
Teks kajian rasmi (Bahasa Inggeris)
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 70 · Wanita · Dikemas kini 29 Sep 2026 · NCT06649201Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
- The Ohio State University, Columbus
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06450925A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- The Ohio State University Comprehensive Cancer Center, Columbus
Mengambil pesertaFasa 2
Umur 2 ke atas · Semua jantina · Dikemas kini 16 Jun 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT06615050Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
- Ohio State University Comprehensive Cancer Center, Columbus
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2026 · NCT07356245Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
- Ohio State University Medical Center, Columbus
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Mac 2026 · NCT03533816A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Cleveland Clinic, Cleveland
- The Ohio State University Comprehensive Cancer Center, Columbus
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT06619561Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.